Triglav Skladi D.O.O. Has $20.71 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Triglav Skladi D.O.O. reduced its stake in UnitedHealth Group by 13.5% during the first quarter, holding now $20.71 million in shares, which accounts for about 1.7% of its portfolio.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, representing an annualized yield of 3.4% and a payout ratio of 38.30%.
• Despite recent analyst rating downgrades, UnitedHealth Group has received a mix of ratings, with three analysts rating it as a sell, seven as hold, and fifteen as buy, reflecting a general sentiment of "Hold" with an average target price of $366.52.

Triglav Skladi D.O.O. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 39,548 shares of the healthcare conglomerate's stock after selling 6,175 shares during the quarter. UnitedHealth Group accounts for about 1.7% of Triglav Skladi D.O.O.'s portfolio, making the stock its 16th biggest position. Triglav Skladi D.O.O.'s holdings in UnitedHealth Group were worth $20,713,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $26,000. Bayforest Capital Ltd lifted its holdings in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Kapitalo Investimentos Ltda purchased a new stake in UnitedHealth Group in the 4th quarter worth $41,000. Finally, Copia Wealth Management purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $42,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday, May 14th. Barclays restated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Truist Financial reduced their price target on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research report on Wednesday, July 16th. KeyCorp dropped their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $366.52.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 107,575 shares of company stock valued at $31,022,334 in the last ninety days. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 3.7%

NYSE UNH opened at $261.59 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm has a market capitalization of $237.30 billion, a PE ratio of 11.33, a P/E/G ratio of 1.63 and a beta of 0.43. The stock's 50 day moving average is $289.94 and its 200 day moving average is $402.24.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 EPS. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 3.4%. UnitedHealth Group's payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.